Novartis AG 2013 SR
The report highlights Novartis's 2013 progress in expanding healthcare access and responsible business practices. Key achievements include reaching 1.2 billion people with medicines and delivering 75 million antimalarial treatments without profit. The company completed a best-in-class materiality assessment and was included in the Dow Jones Sustainability World Index. Environmental milestones include a 13.7% reduction in total greenhouse gas emissions compared to 2008 and achieving 2015 energy saving targets two years early. The report also details the establishment of a new Governance, Nomination and Corporate Responsibility Committee to oversee ESG strategy.
Company: Novartis AG
Sector: Manufacturing
Country: Switzerland
Year: 2013
Type: SR
Pages: 105
Novartis AG
The report highlights Novartis's 2013 progress in expanding healthcare access and responsible business practices. Key achievements include reaching 1.2 billion people with medicines and delivering 75 million antimalarial treatments without profit. The company completed a best-in-class materiality assessment and was included in the Dow Jones Sustainability World Index. Environmental milestones include a 13.7% reduction in total greenhouse gas emissions compared to 2008 and achieving 2015 energy saving targets two years early. The report also details the establishment of a new Governance, Nomination and Corporate Responsibility Committee to oversee ESG strategy.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2013
Reporting Period
Jan 1, 2013 - Dec 31, 2013
Fiscal Year
2013
Published
Jul 1, 2014
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees